News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
111 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28348)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3627)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
2 (13)
3 (111)
4 (147)
5 (162)
6 (150)
7 (96)
9 (24)
10 (101)
11 (117)
12 (135)
13 (125)
14 (151)
17 (94)
18 (131)
19 (207)
20 (168)
21 (96)
24 (160)
25 (182)
26 (291)
27 (213)
28 (94)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
9
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Psychedelics
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks after J&J secured FDA monotherapy approval for its esketamine nasal spray Spravato in the same indication.
February 3, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Leber Congenital Amaurosis Market Expected to Exhibit a CAGR of 3.60% During 2025-2035, Impelled by Increasing Awareness and Genetic Testing.
February 3, 2025
·
10 min read
Press Releases
Lumbar Spondylolisthesis Market Expected to Exhibit a CAGR Of 3.66% During 2025-2035, Impelled by Advancements in Early Detection
February 3, 2025
·
6 min read
Press Releases
Lymphangioleiomyomatosis Market Size to Reach USD 129.7 Million by 2035, Impelled by Advancements in Early Detection and Gene Therapy.
February 3, 2025
·
7 min read
Press Releases
Iron Overload Syndrome Market Predicted to Grow at a Steady CAGR of 4.91% during 2025-2035, Impelled by Rising Prevalence of Iron-Related Disorders
February 3, 2025
·
8 min read
Press Releases
Liver Fibrosis Market Size to Reach USD 5.4 Billion by 2035, Impelled by Advancements in Targeted Therapy and Personalized Medicine.
February 3, 2025
·
8 min read
Press Releases
Lenegre’s Disease Market Size to Reach USD 1,682.0 Million by 2035, Impelled by Rising Geriatric Population.
February 3, 2025
·
6 min read
Press Releases
Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis
February 3, 2025
·
3 min read
Press Releases
First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak
February 3, 2025
·
3 min read
Press Releases
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.
February 3, 2025
·
4 min read
Previous
10 of 12
Next